IMPORTANCE Surgical excision is the standard-of-care treatment for Tis and T1a melanomas of the head and neck. Currently, however, the association of diagnosis and surgical treatment of these typically slowly progressive and nonfatal melanomas with a patient's health-related quality of life (HRQoL) is unknown.
T is and T1a melanomas of the head and neck have an excellent prognosis, with more than a 98% five-year disease-specific survival 1 ; however, the association of treatment with health-related quality of life (HRQoL) is not currently known. Melanoma in sun-exposed areas of the head and neck is known for substantial subclinical extension and thus presents distinct treatment challenges. Standard excision margins are often inadequate for clearance of melanoma in these locations, resulting in large surgical defects and reconstruction. [2] [3] [4] These considerations, as well as the common public perception of melanoma as a life-threatening cancer, may uniquely affect patient HRQoL. Health-related quality of life impairment among patients with melanoma may be largely psychological, 5 as patients have reported high levels of anxiety and distress even before receiving histologic confirmation baof their diagnosis. 6 Scarring, particularly in conspicuous areas, must also be considered. A better understanding of patients' HRQoL throughout the diagnosis, treatment, and recovery processes will enable clinicians to provide comprehensive, patient-centered care. Therefore, the objectives of this study were to characterize and assess HRQoL in patients with Tis or T1a melanoma of the head and neck, evaluate the long-and short-term changes in HRQoL over the course of surgical treatment, and describe the patient characteristics associated with lower HRQoL. 9 Higher scores indicate worse HRQoL in Skindex-16 but better HRQoL in SCI. All participants completed a set of PROM instruments prior to the surgical procedure, and the questionnaires were administered again at the 1-to 2-week perioperative time point as well as at the 6-month and 1-year postoperative time points. If the patient was unable to come to the follow-up, the questionnaire was mailed to the patient. The following data were collected from the medical record of each patient: age, sex, race/ethnicity, marital status, comorbidities, history of anxiety or depression, tumor location, and biopsy result. Descriptive statistics were used to describe the patient population and the results of the questionnaires. Geometric means and SDs were used because of the skewed nature of the Skindex-16 and SCI distributions. Unpaired, 2-tailed t tests and 1-way analysis of variance were used to assess differences in the distribution of scores between subsets of the patient population. A 2-sided P < .05 was used to indicate statistical significance. Separate random-effects regression models were used to assess the change in HRQoL measures over time. The potential interaction between patient sex and evaluation time point was assessed. Model-based predictive marginal probabilities were plotted to visualize the trajectories of scores for male and female participants. All analyses were performed using Stata, version14.2 (StataCorp LLC).
Methods

Results
Fifty-six patients completed baseline PROM instruments prior to their surgical procedure. Among these patients, 24 (43%) were female and 32 (57%) were male, with a mean (range) age of 67. In total, 41 questionnaires (73%) at perioperative, 49 (88%) at 6-month postoperative, and 41 (73%) at 1-year postoperative time points were completed. Differences in mean Skindex-16 and SCI scores at these time points are shown in Table 2 . At baseline, the emotions subscale of both PROM instruments showed the greatest changes in HRQoL. On the Skindex-16 questionnaire, the total score was statistically significantly worse at the perioperative time point compared with baseline (26.3 vs 14.6; P < .001) but improved at the 1-year postoperative time point from the baseline (9.4 vs 14.6; P = .04). The total SCI score improved from baseline to 6-month (68.8 vs 81.5; P < .001) and 1-year (68.8 vs 82.9;
Key Points
Question What is the association between surgical excision of Tis and T1a melanomas of the head and neck and the health-related quality of life of a patient?
Findings In this longitudinal cohort study involving 56 patients with a Tis or T1a melanoma of the head and neck, patient-reported health-related quality of life was worse in the perioperative period but improved to above baseline levels by 6 months and 1 year after excision of the tumor. Women and those younger than 65 years experienced worse health-related quality of life over the treatment course.
Meaning Surgical excision of Tis and T1a melanomas of the head and neck may be associated with long-term net improvement of health-related quality of life; baseline or preoperative counseling may be tailored to groups at risk of lower health-related quality of life. 
Discussion
This study demonstrated a decline in perioperative HRQoL that subsequently improved to above baseline levels by 6 months and 1 year after the surgical procedure in patients with Tis or T1a melanoma of the head and neck. The Skindex-16 and SCI questionnaires addressed different aspects of HRQoL at various time points, providing a more comprehensive picture of change in HRQoL than was previously understood. Skindex-16 responses reflected the perioperative symptomatic and social changes in HRQoL, whereas the SCI responses highlighted the long-term improvement in HRQoL, particularly regarding appearance. Understanding the unique HRQoL changes in these patients is crucial in developing effective counseling and follow-up interventions for a growing patient population.
At baseline, the emotions subscale of both PROMs showed the greatest change in HRQoL, which is consistent with previous findings demonstrating elevated psychological distress in patients with melanoma.
10,11 A study of 520 patients with melanoma found that most of the identified distress was emotional in nature (eg, worry, sadness). Furthermore, elevated levels of distress were not associated with tumor stage, an interesting finding given the substantial variability in stage-dependent prognosis. 12 The results from this study support previous findings of patients with melanoma experiencing considerable emotional distress largely associated with fear or worry about future occurrence or recurrence of skin cancer.
10, 12, 13 Both PROM instruments revealed younger (<65 years) and female patients to have statistically significantly worse HRQoL at baseline. A previous study found a greater percentage of women, compared with men, with clinically elevated levels of anxiety about their melanoma diagnosis. 6 In another study, younger and female patients had significantly worse SCI scores before, 1 to 2 weeks after, and 3 months after a Mohs micrographic operation. 14 In our study, the difference in scores by sex diminished over time, whereas the difference in scores by age remained through the first postoperative year. Further research is needed into HRQoL implications, but they may be most pronounced for female patients in the early treatment Shown are the predicted Skindex-16 (A) and SCI (B) scores by sex as well as the predicted Skindex-16 (C) and SCI (D) scores by age at each evaluation time point, using the random-effects model. All models were adjusted for patient age. For the Skindex-16 questionnaire, lower scores indicated better quality of life (QoL), whereas for the SCI questionnaire, higher scores reflected better QoL. A P < .05 denoted a statistically significant difference in scores by age.
period and may continue in the long term for younger patients. Interestingly, the visibility of the tumor and the repair type, which may affect scarring, were not associated with substantial changes in HRQoL. The overall long-term improvement in HRQoL shows that, despite the potential for scarring, removal of the tumor is a substantial factor in this improvement. Future studies using multimodule, skin cancer-specific PROM instruments, such as the FACE-Q Skin Cancer Module, 15 may capture important disease-and treatment-associated concerns in this patient population.
Limitations
Limitations of this study include the relatively small sample size from a single tertiary care center. In addition, measurement bias may have been present in patients who completed the questionnaires in-office, although we took efforts to diminish this bias. Lastly, we only studied patients who underwent surgical excision; future studies may assess the changes associated with different treatment modalities.
Conclusions
Patients who underwent surgical treatment for early-stage head and neck melanoma reported an overall long-term improvement in HRQoL, which may indicate that surgical treatment of the tumor is associated with better HRQoL. A greater change in HRQoL was seen in women and those younger than 65 years. Physicians may use this information to tailor counseling for patients.
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